RT @BritishHIVAssoc: After the HIV cure session, @ProfYGilleece speaks with @sarahfidler4 on the challenges and ethics of cure studies #hiv….

On the other site now. Drmjlee dot Bluesky dot social. Looking forward to reconnect with friends and colleagues there!.

RT @jiasociety: This meta-analysis evaluated the impact of analytical treatment interruptions and trial interventions on time to viral re-s….

RT @erica_pool: What's new in the DRAFT 2024 #PrEP guidelines*?. ▶️Vital review of access & equity.▶️Goodbye limited trial based indicators….

RT @lenkavod: Recommend applying for this opportunity to get behind the scenes and be a part of an International editorial team at the jour….

RT @johnthejack: Scotland has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV be….

RT @nicolamlow: Matt Golden on #DoxyPEP with a balanced and realistic view of pros and cons. “Patients on doxy-PEP take approximately 43….

RT @nicolamlow: This is what a true researcher is. Answer the questions and follow the evidence. #Chlamydia screening may not do more good….

Who and when to test for #MGen - still clear as mud? Even expert guidelines panels, looking at the same evidence, give rise to differing recommendations!. Key principles, avoid unnecessary testing in asymptomatic pts, and limit abx use to those who will benefit. #IUSTI2024

How to get sexual health doctors and researchers up early. By putting the 'Testing for Mycoplasma genitalium' satellite at 7.30am. #IUSTI2024

A poignant piece of work by Ben Riley on what PrEP means for gay men - a memory pill by removing HIV anxiety and allowing gya men to imagine what sex pre-HIV era was like @ASHMMedia #HIVAIDS2024

Dr @michael_moso : a novel CRISPR - lipid nanoparticle(LNP) given alongside TAT-LNP was synergistic in latency reversal of HIV in vitro. Exciting implications for future shock and kill strategies, but more work needed to understand safety and efficacy of invivo use. #IUSTI2024

Novel proteomics methods may allow us to move away from NAATs based assays.

But challenges and questions remains, in our mechanistic understanding of syphilis pathogenesis, as well as gaps with better diagnostics, and implementation are much needed!

There have been some really promising scientific progress in our understanding of syphilis pathology. 1. Animal-free cell cultures.2. Genetic manipulation and whole genome sequencing of syphilis.3. Culture model to estimate MICs for new abx.4. More effective BPG administration

A masterful overview of the challenges and developments addressing global syphilis epidemic by @dr_michaelmarks.#IUSTI2024. It is not one global epidemic but differs by regions, with the highest burdens reported in sub-saharan African regions.

#IUSTI2024 opens with a traditional smoking ceremony by Raymond Weatherall from the MLALC. @ASHMMedia @IUSTI_World

RT @JillianLau1: After a quick coffee Prof Monica Gandhi is back presenting on #HIV in Women in a special session on managing and optimisin….

Marti Kaiser @AlfredHealth demonstrating the use of a volunteer database to engage people living with HIV to participate in cure-related studies. To date 315 people have signed up, with high levels of interest even with invasive procedures eg. Tissue donation. #HIVAIDS2024

Subtype A1 no longer a concern. A6 remains a concern for failure of LA CAB/RPV